PROFECTUS BIOSCIENCES, INC.

Organization

BALTIMORE, MD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Recombinant isfahan viral vectors
- Patent number 9,932,564
- Issue date Apr 3, 2018
- The Board of Regents of the University of Texas System
- Demetrius Matassov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of NF-κB
- Patent number 8,629,164
- Issue date Jan 14, 2014
- Profectus Biosciences, Inc.
- Jie Zhang
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
RECOMBINANT ISFAHAN VIRAL VECTORS
- Publication number 20170067027
- Publication date Mar 9, 2017
- The Board of Regents of the University of Texas System
- Demetrius Matassov
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting Th...
- Publication number 20120088827
- Publication date Apr 12, 2012
- Profectus Biosciences, Inc.
- Jie Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kapp...
- Publication number 20120046357
- Publication date Feb 23, 2012
- Profectus Biosciences, Inc.
- Jie Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of NF-KB
- Publication number 20120015952
- Publication date Jan 19, 2012
- Profectus Biosciences, Inc.
- Jie Zhang
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
78652831 - PROFECTUS
- Serial number 78652831
- Registration number 3514093
- Filing date Jun 17, 2005
- Profectus Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
78625305 - PROFECTUS BIOSCIENCES, INC.
- Serial number 78625305
- Registration number 3173338
- Filing date May 9, 2005
- Profectus Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 30

Research Projects

Information Research Project
Sonoporation as a novel delivery platform for an HIV DNA vaccine
- Application id 9846197
- Award notice date Jan 2, 2020
Information Research Project
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine
- Application id 9777862
- Award notice date Apr 23, 2019
Information Research Project
Sonoporation as a novel delivery platform for an HIV DNA vaccine
- Application id 9695517
- Award notice date Jan 7, 2019
Information Research Project
Optimization of an innate immune stimulating adjuvant for an HIV DN...
- Application id 9474304
- Award notice date Aug 28, 2018
Information Research Project
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
- Application id 9319619
- Award notice date Jul 13, 2017
Information Research Project
Therapeutic Vaccine for Walnut and Pecan Allergies
- Application id 9409272
- Award notice date Jun 5, 2017
Information Research Project
Novel Mucosal Adjuvant for an HIV DNA Vaccine
- Application id 9306778
- Award notice date Jun 1, 2017
Information Research Project
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
- Application id 9130747
- Award notice date Jul 21, 2016
Information Research Project
An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC
- Application id 9114474
- Award notice date Jul 14, 2016
Information Research Project
Novel Mucosal Adjuvant for an HIV DNA Vaccine
- Application id 9064339
- Award notice date Jun 29, 2016
Information Research Project
DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine
- Application id 9200165
- Award notice date Jun 14, 2016
Information Research Project
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
- Application id 9058458
- Award notice date Apr 25, 2016
Information Research Project
Development of sG as a human vaccine against Nipah/Hendra
- Application id 9055627
- Award notice date Apr 25, 2016
Information Research Project
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
- Application id 9090608
- Award notice date Aug 21, 2015
Information Research Project
An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC
- Application id 8910632
- Award notice date Jul 22, 2015
Information Research Project
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
- Application id 8837561
- Award notice date Apr 23, 2015
Information Research Project
Development of sG as a human vaccine against Nipah/Hendra
- Application id 8837560
- Award notice date Apr 16, 2015
Information Research Project
Optimization of a DNA Subunit Regimen for an HIV Vaccine
- Application id 8840144
- Award notice date Apr 15, 2015
Information Research Project
Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...
- Application id 8843265
- Award notice date Apr 13, 2015
Information Research Project
An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC
- Application id 8789098
- Award notice date Aug 11, 2014
Information Research Project
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
- Application id 8789075
- Award notice date Jun 20, 2014
Information Research Project
Optimization of an innate immune stimulating adjuvant for an HIV DN...
- Application id 8789040
- Award notice date Jun 13, 2014
Information Research Project
Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...
- Application id 8667308
- Award notice date Apr 29, 2014
Information Research Project
Optimization of a DNA Subunit Regimen for an HIV Vaccine
- Application id 8658372
- Award notice date Apr 18, 2014
Information Research Project
Development of sG as a human vaccine against Nipah/Hendra
- Application id 8651872
- Award notice date Apr 11, 2014
Information Research Project
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
- Application id 8653530
- Award notice date Apr 11, 2014
Information Research Project
Optimization of a DNA Subunit Regimen for an HIV Vaccine
- Application id 8810334
- Award notice date Mar 19, 2014
Information Research Project
Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...
- Application id 8452173
- Award notice date May 28, 2013
Information Research Project
Optimization of a DNA Subunit Regimen for an HIV Vaccine
- Application id 8642864
- Award notice date May 3, 2013
Information Research Project
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
- Application id 8464630
- Award notice date Apr 17, 2013

PROFECTUS BIOSCIENCES, INC.

Organization

Patents Grantslast 30 patents

Recombinant isfahan viral vectors

Inhibitors of NF-κB

Patents Applicationslast 30 patents

RECOMBINANT ISFAHAN VIRAL VECTORS

Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting Th...

Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kapp...

Inhibitors of NF-KB

Trademarklast 30 trademarks

78652831 - PROFECTUS

78625305 - PROFECTUS BIOSCIENCES, INC.

NIH Research Projectlast 12 months

Research Projects

Sonoporation as a novel delivery platform for an HIV DNA vaccine

DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine

Sonoporation as a novel delivery platform for an HIV DNA vaccine

Optimization of an innate immune stimulating adjuvant for an HIV DN...

Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

Therapeutic Vaccine for Walnut and Pecan Allergies

Novel Mucosal Adjuvant for an HIV DNA Vaccine

Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC

Novel Mucosal Adjuvant for an HIV DNA Vaccine

DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine

rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses

Development of sG as a human vaccine against Nipah/Hendra

Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC

rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses

Development of sG as a human vaccine against Nipah/Hendra

Optimization of a DNA Subunit Regimen for an HIV Vaccine

Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...

An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC

Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

Optimization of an innate immune stimulating adjuvant for an HIV DN...

Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...

Optimization of a DNA Subunit Regimen for an HIV Vaccine

Development of sG as a human vaccine against Nipah/Hendra

rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses

Optimization of a DNA Subunit Regimen for an HIV Vaccine

Preclinical Development of m102.4, a Human Anti-Hendra and Nipah An...

Optimization of a DNA Subunit Regimen for an HIV Vaccine

rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses